awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40863917-850AF1A4-94F4-4C54-9E6C-81F8F6BEB960
Q40863917-850AF1A4-94F4-4C54-9E6C-81F8F6BEB960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-850AF1A4-94F4-4C54-9E6C-81F8F6BEB960
(90)Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study.
P304
Q40863917-850AF1A4-94F4-4C54-9E6C-81F8F6BEB960
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40863917-850AF1A4-94F4-4C54-9E6C-81F8F6BEB960
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2106cc4de2c159fe50c0cc7eb8e884e4d051753c
P304
e108-17
http://www.w3.org/2001/XMLSchema#string